Use with warning in perioperative location; individualize treatment when transitioning from parenteral to oral analgesicsConcomitant utilization of oxycodone with CYP3A4 inducers or discontinuation of a CYP3A4 inhibitor could decrease oxycodone plasma concentrations, reduce opioid efficacy or, perhaps, lead to a withdrawal syndrome in the individua